B-cell-directed therapy for chronic graft-versus-host disease

Haematologica. 2010 Nov;95(11):1811-3. doi: 10.3324/haematol.2010.032227.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Monoclonal, Murine-Derived / administration & dosage*
  • B-Cell Activating Factor / blood
  • B-Lymphocytes / metabolism
  • Chemical and Drug Induced Liver Injury / blood
  • Chemical and Drug Induced Liver Injury / therapy
  • Child
  • Chronic Disease
  • Diabetes Mellitus / blood
  • Diabetes Mellitus / therapy
  • Female
  • Graft vs Host Disease / blood
  • Graft vs Host Disease / drug therapy*
  • Graft vs Host Disease / metabolism
  • Hematologic Neoplasms / blood
  • Hematologic Neoplasms / therapy
  • Humans
  • Immunologic Factors / administration & dosage*
  • Male
  • Middle Aged
  • Prospective Studies
  • Rituximab
  • Stem Cell Transplantation
  • Steroids / therapeutic use
  • Transplantation, Homologous
  • Tuberculosis / blood
  • Tuberculosis / therapy

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • B-Cell Activating Factor
  • Immunologic Factors
  • Steroids
  • Rituximab